Gainers
- Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800 series.
- Workhorse Group Inc. (NASDAQ:WKHS) shares rose 19.5% to $0.7590 in pre-market trading after the company announced it has received IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit.
- Super League Enterprise, Inc. (NASDAQ:SLE) shares gained 16.9% to $2.28 in pre-market trading after falling 40% on Tuesday.
- Bit Brother Limited (NASDAQ:BETS) shares rose 16.8% to $0.6896 in pre-market trading. In Dec. 2022, Bit Brother, through its subsidiary in New York, Bit Brother New York Inc, entered into a "Hedged Electricity Price" power supply agreement with a retail electricity provider (REP) within the jurisdiction of the Electric Reliability Council of Texas (ERCOT) for a term of 5 years.
- Mainz Biomed N.V. (NASDAQ:MYNZ) rose 16.6% to $4.27 in pre-market trading. Mainz Biomed's ColoFuture study, evaluating its novel mRNA biomarkers, reported groundbreaking topline results demonstrating sensitivity for colorectal cancer of 94% with specificity of 97% and advanced adenoma sensitivity of 81%.
- Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose 16.3% to $17.78 in pre-market trading. Rocket Pharmaceuticals announced pricing of public offering of common stock.
- Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) shares climbed 16.1% to $7.00 in pre-market trading after jumping 15% on Tuesday.
- FaZe Holdings Inc. (NASDAQ:FAZE) gained 13.3% to $0.2075 in pre-market trading after declining 13% on Tuesday.
- DIRTT Environmental Solutions Ltd. (NASDAQ:DRTT) shares surged 11.7% to $0.3797 in pre-market trading after surging 15% on Tuesday.
- Axcella Health Inc. (NASDAQ:AXLA) shares jumped 11.4% to $1.27 in pre-market trading after jumping more than 59% on Tuesday.
Losers
Now Read This: Cracker Barrel, REV Group And 3 Stocks To Watch Heading Into Wednesday
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
